Financial Ratios Sonova Holding AG
Stocks
SOON
CH0012549785
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205.40 CHF | -0.87% |
|
+1.18% | -0.82% |
| 16/07 | MedTech facing a three-front squeeze | ![]() |
| 23/06 | Morgan Stanley Upgrades Sonova to Equalweight, Boosts PT | MT |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.52 | 8.8 | 7.79 | 8 | 7.63 | |||||
Return on Total Capital | 11.51 | 12.31 | 10.61 | 10.74 | 10.02 | |||||
Return On Equity % | 25.5 | 28.22 | 25.81 | 21.13 | 20.52 | |||||
Return on Common Equity | 25.16 | 28.01 | 25.67 | 21.05 | 20.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 73.23 | 70.76 | 72.28 | 72.43 | 73.72 | |||||
SG&A Margin | 42.72 | 43.27 | 46.2 | 46.99 | 47.53 | |||||
EBITDA Margin % | 26.55 | 24.4 | 23.06 | 22.82 | 23.34 | |||||
EBITA Margin % | 24.6 | 22.44 | 21.08 | 20.9 | 21.91 | |||||
EBIT Margin % | 23.32 | 20.97 | 19.5 | 19.4 | 19.55 | |||||
Income From Continuing Operations Margin % | 19.73 | 17.61 | 16.8 | 14.15 | 15.14 | |||||
Net Income Margin % | 19.29 | 17.32 | 16.57 | 13.98 | 11.94 | |||||
Net Avail. For Common Margin % | 19.29 | 17.32 | 16.57 | 13.98 | 14.9 | |||||
Normalized Net Income Margin | 13.55 | 12.3 | 11.56 | 11.31 | 11.38 | |||||
Levered Free Cash Flow Margin | 20.42 | 12.19 | 15.39 | 13.12 | 9.6 | |||||
Unlevered Free Cash Flow Margin | 20.81 | 12.58 | 15.87 | 13.55 | 10.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.58 | 0.67 | 0.64 | 0.66 | 0.62 | |||||
Fixed Assets Turnover | 5.64 | 6.03 | 5.84 | 6.47 | 6.35 | |||||
Receivables Turnover (Average Receivables) | 7.32 | 7.43 | 6.77 | 6.88 | 6.47 | |||||
Inventory Turnover (Average Inventory) | 2.52 | 2.63 | 2.35 | 2.36 | 2.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.1 | 1.37 | 1.45 | 1.27 | 1.75 | |||||
Quick Ratio | 0.79 | 0.93 | 1.01 | 0.91 | 1.16 | |||||
Operating Cash Flow to Current Liabilities | 0.63 | 0.71 | 0.66 | 0.53 | 0.6 | |||||
Days Sales Outstanding (Average Receivables) | 49.87 | 49.1 | 54.02 | 53.06 | 56.39 | |||||
Days Outstanding Inventory (Average Inventory) | 144.89 | 138.86 | 155.55 | 154.83 | 163.61 | |||||
Average Days Payable Outstanding | 52.78 | 63.42 | 70.78 | 78.31 | 94.66 | |||||
Cash Conversion Cycle (Average Days) | 141.98 | 124.55 | 138.8 | 129.58 | 125.34 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 61.01 | 81.33 | 72.03 | 65.58 | 64.94 | |||||
Total Debt / Total Capital | 37.89 | 44.85 | 41.87 | 39.61 | 39.37 | |||||
LT Debt/Equity | 44.41 | 77.81 | 68.85 | 49.48 | 57.87 | |||||
Long-Term Debt / Total Capital | 27.58 | 42.91 | 40.02 | 29.88 | 35.09 | |||||
Total Liabilities / Total Assets | 56.47 | 59.81 | 56.99 | 54.68 | 53.17 | |||||
EBIT / Interest Expense | 37.36 | 33.5 | 25.08 | 28.3 | 24.56 | |||||
EBITDA / Interest Expense | 45.62 | 42.12 | 32.39 | 36.09 | 31.87 | |||||
(EBITDA - Capex) / Interest Expense | 41.84 | 37.97 | 29.37 | 32.7 | 29.04 | |||||
Total Debt / EBITDA | 1.55 | 1.84 | 1.96 | 1.84 | 1.87 | |||||
Net Debt / EBITDA | 0.91 | 1.42 | 1.4 | 1.12 | 1.08 | |||||
Total Debt / (EBITDA - Capex) | 1.69 | 2.04 | 2.17 | 2.03 | 2.05 | |||||
Net Debt / (EBITDA - Capex) | 0.99 | 1.58 | 1.55 | 1.24 | 1.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.29 | 11.13 | -2.98 | 6.58 | -0.19 | |||||
Gross Profit, 1 Yr. Growth % | 31.35 | 7.38 | -0.9 | 6.8 | -0.97 | |||||
EBITDA, 1 Yr. Growth % | 44.28 | 2.13 | -8.3 | 4.61 | -1 | |||||
EBITA, 1 Yr. Growth % | 49.18 | 1.37 | -8.87 | 4.72 | -0.16 | |||||
EBIT, 1 Yr. Growth % | 53.18 | -0.09 | -9.77 | 5 | -3.93 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 13.39 | -0.83 | -7.4 | -10.27 | -3.33 | |||||
Net Income, 1 Yr. Growth % | 11.7 | -0.23 | -7.18 | -10.07 | -20.33 | |||||
Normalized Net Income, 1 Yr. Growth % | 49.97 | 0.88 | -8.77 | 3.19 | -4.57 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 12.62 | 3.57 | -6.25 | -10.05 | -3.53 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.01 | 10.73 | 2.59 | 7.27 | -8.44 | |||||
Inventory, 1 Yr. Growth % | 36.52 | 1.55 | 3.94 | 7.55 | -18.68 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.89 | 3.08 | -2.83 | -4.77 | -5.03 | |||||
Total Assets, 1 Yr. Growth % | -5.69 | -0.64 | 4.31 | 2.29 | -4.99 | |||||
Tangible Book Value, 1 Yr. Growth % | -195.09 | 57.04 | -35.53 | -51.51 | -131.63 | |||||
Common Equity, 1 Yr. Growth % | -12.28 | -8.22 | 11.66 | 7.86 | -1.9 | |||||
Cash From Operations, 1 Yr. Growth % | 23.12 | -16.7 | -3.9 | 5.36 | -10.86 | |||||
Capital Expenditures, 1 Yr. Growth % | 24.61 | 21.89 | -11.97 | 5.28 | -2.98 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 77.26 | -33.64 | 22.48 | -9.82 | -28.89 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 75.8 | -32.83 | 22.42 | -9.71 | -27.71 | |||||
Dividend Per Share, 1 Yr. Growth % | 37.5 | 4.55 | -6.52 | 2.33 | 6.82 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.39 | 19.87 | 3.84 | 1.68 | -0.29 | |||||
Gross Profit, 2 Yr. CAGR % | 8.41 | 18.77 | 3.16 | 2.88 | 0.7 | |||||
EBITDA, 2 Yr. CAGR % | 14.8 | 21.39 | -3.23 | -1.65 | -0.11 | |||||
EBITA, 2 Yr. CAGR % | 16.34 | 22.97 | -3.89 | -1.87 | 1.21 | |||||
EBIT, 2 Yr. CAGR % | 17.63 | 23.71 | -5.05 | -2.19 | -0.66 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 16.44 | 6.04 | -4.17 | -8.85 | -5.35 | |||||
Net Income, 2 Yr. CAGR % | 15.89 | 5.57 | -3.77 | -8.64 | -15.36 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.21 | 23 | -4.07 | -2.47 | -1.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 16.93 | 8 | -1.46 | -8.17 | -5.32 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.34 | 9.36 | 6.58 | 4.9 | -0.9 | |||||
Inventory, 2 Yr. CAGR % | 24.7 | 17.74 | 2.74 | 5.73 | -6.48 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.86 | 3.98 | 0.08 | -3.8 | -4.9 | |||||
Total Assets, 2 Yr. CAGR % | 11.6 | -3.2 | 1.81 | 3.29 | -1.42 | |||||
Tangible Book Value, 2 Yr. CAGR % | 28.47 | 36.77 | -5.47 | -44.08 | -60.83 | |||||
Common Equity, 2 Yr. CAGR % | 9.48 | -10.27 | 1.23 | 9.74 | 2.86 | |||||
Cash From Operations, 2 Yr. CAGR % | 5.64 | 1.27 | -10.53 | 0.62 | -3.09 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.33 | 23.24 | 3.58 | -3.73 | -2.31 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 3.57 | 8.43 | -9.85 | 5.5 | -21.55 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4.25 | 8.67 | -9.32 | 5.53 | -20.78 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 19.9 | -1.14 | -2.2 | 4.55 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.78 | 8.62 | 11.71 | 4.74 | -1.2 | |||||
Gross Profit, 3 Yr. CAGR % | 7.64 | 8.07 | 11.81 | 4.36 | 0.16 | |||||
EBITDA, 3 Yr. CAGR % | 11.01 | 10.41 | 10.55 | -0.41 | -2.65 | |||||
EBITA, 3 Yr. CAGR % | 11.93 | 11.12 | 11.28 | -0.8 | -1.97 | |||||
EBIT, 3 Yr. CAGR % | 13 | 11.4 | 11.36 | -1.5 | -3.48 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 12.98 | 10.37 | 1.36 | -6.25 | -6.04 | |||||
Net Income, 3 Yr. CAGR % | 12.64 | 10.25 | 1.13 | -5.92 | -12.71 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.4 | 10.22 | 11.34 | -1.37 | -3.73 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.2 | 12.3 | 3.03 | -4.41 | -5.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.03 | 11.14 | 7.06 | 6.81 | 0.25 | |||||
Inventory, 3 Yr. CAGR % | 13.52 | 16.45 | 12.95 | 4.32 | -3.13 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 24.7 | 2.93 | 1.66 | -1.56 | -4.21 | |||||
Total Assets, 3 Yr. CAGR % | 9.19 | 7.36 | -0.76 | 1.97 | 0.46 | |||||
Tangible Book Value, 3 Yr. CAGR % | 151.87 | 48.08 | 2.1 | -24.33 | -53.75 | |||||
Common Equity, 3 Yr. CAGR % | 0.8 | 3.23 | -3.49 | 3.4 | 5.72 | |||||
Cash From Operations, 3 Yr. CAGR % | 20.85 | -2.41 | -0.49 | -5.52 | -3.36 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.07 | 2.99 | 10.16 | 4.14 | -5.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.82 | -10.73 | 12.92 | -9.61 | -8.76 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.43 | -9.96 | 13.07 | -9.22 | -8.18 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.91 | - | 10.35 | 0 | 0.72 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.02 | 7.16 | 5.59 | 5.79 | 6.74 | |||||
Gross Profit, 5 Yr. CAGR % | 8.32 | 7.2 | 5.83 | 5.96 | 7.23 | |||||
EBITDA, 5 Yr. CAGR % | 11.33 | 8.47 | 5.08 | 5.42 | 6.33 | |||||
EBITA, 5 Yr. CAGR % | 12.17 | 9.02 | 5.31 | 5.73 | 7.33 | |||||
EBIT, 5 Yr. CAGR % | 12.95 | 9.63 | 5.4 | 5.75 | 6.59 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 13.26 | 10.07 | 5.78 | 2.24 | -1.38 | |||||
Net Income, 5 Yr. CAGR % | 13.2 | 10.11 | 5.77 | 2.27 | -5.82 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.25 | 8.95 | 4.94 | 4.96 | 6.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.15 | 11.9 | 7.66 | 3.61 | -0.39 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.92 | 3.29 | 0.7 | 8.6 | 3.8 | |||||
Inventory, 5 Yr. CAGR % | 10.05 | 9.64 | 9.08 | 12.04 | 4.74 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 14.92 | 15.61 | 14.2 | 0.18 | -1.02 | |||||
Total Assets, 5 Yr. CAGR % | 7.26 | 5.24 | 6.17 | 5.72 | -1.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | 30.38 | 52.24 | 78.03 | -2.17 | -30.4 | |||||
Common Equity, 5 Yr. CAGR % | 2.71 | -2.03 | 0.97 | 5.79 | -1 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.49 | 8.41 | 7.16 | -1.2 | -1.54 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.14 | 9.63 | 2.07 | 0.25 | 4.99 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.45 | 5.83 | 7.46 | -4.56 | -2.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.81 | 6.45 | 8.04 | -4.06 | -1.78 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.85 | 12.09 | 8.2 | - | 7.99 |
- Stock Market
- Stocks
- SOON Stock
- Financials Sonova Holding AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















